OTHER GROUP COMPANIES
market

Glenmark Pharmaceuticals receives ANDA approval for Calcipotriene Cream, 0.005%

Glenmark Pharmaceuticals receives ANDA approval for Calcipotriene Cream, 0.005%

June 11, 2015 12:00 IST | capital market
Glenmark Pharmaceuticals has been granted final approval by the United State Food & Drug Adminstration for Calcipotriene Cream, 0.005%, the therapeutic equivalent of Dovonex Cream, 0.005% of Leo Pharma A/S. Glenmark plans to commence shipping of Calcipotriene Cream, 0.005% immediately.

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000

FEATURED ARTICLE

BLOGS

Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity